Carcinogenesis, Teratogenesis & Mutagenesis ›› 2020, Vol. 32 ›› Issue (4): 321-324.doi: 10.3969/j.issn.1004-616x.2020.04.014
Previous Articles Next Articles
Received:2020-01-06
Revised:2020-06-09
Online:2020-07-31
Published:2020-08-01
CLC Number:
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
| [1] LIU M L, ZHONG J X, ZENG Z, et al. Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein[J]. Theranostics, 2019, 9(16):4795-4810. [2] MOLDOGAZIEVA N T, MOKHOSOEV I M, TERENTIEV A A. Metabolic heterogeneity of cancer cells:an interplay between HIF-1, GLUTs, and AMPK[J]. Cancers (Basel), 2020, 12(4):E862. [3] CHOUDHRY H, HARRIS A L, MCINTYRE A. The tumour hypoxia induced non-coding transcriptome[J]. Mol Aspects Med, 2016, 47/48:35-53. [4] FLIPPOT R, BEINSE G, BOILÈVE A, et al. Long non-coding RNAs in genitourinary malignancies:a whole new world[J]. Nat Rev Urol, 2019, 16(8):484-504. [5] SHIH J W, KUNG H J. Long non-coding RNA and tumor hypoxia:new players ushered toward an old Arena[J]. J Biomed Sci, 2017, 24(1):53. [6] QIU J J, LIN X J, ZHENG T T, et al. Natural antisense transcript of hypoxia-inducible factor 1 regulates hypoxic cell apoptosis in epithelial ovarian cancer[J]. Onco Targets Ther, 2018, 11:9101-9110. [7] DAI X J, LIAO K M, ZHUANG Z J, et al. AHIF promotes glioblastoma progression and radioresistance via exosomes[J]. Int J Oncol, 2019, 54(1):261-270. [8] CAI Q, WANG Z Q, WANG S H, et al. Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelial-mesenchymal transition by regulating HIF-1α via miR-138[J]. Open Biol, 2017, 7(1):160247. [9] LIN A F, LI C L, XING Z, et al. The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer[J]. Nat Cell Biol, 2016, 18(2):213-224. [10] WANG Y, CHEN W Y, LIAN J Y, et al. The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α[J]. Cell Death Differ, 2020, 27(2):695-710. [11] ZHAO D, WANG S S, CHU X, et al. LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression[J]. Artif Cells Nanomed Biotechnol, 2019, 47(1):1342-1348. [12] CHEN F, CHEN J N, YANG L B, et al. Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells[J]. Nat Cell Biol, 2019, 21(4):498-510. [13] DENG S J, CHEN H Y, YE Z, et al. Hypoxia-induced lncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription[J]. Oncogene, 2018, 37(44):5811-5828. [14] WU W N, HU Q, NIE E, et al. Hypoxia induces H19 expression through direct and indirect Hif-1α activity, promoting oncogenic effects in glioblastoma[J]. Sci Rep, 2017, 7:45029. [15] ZENG Z, XU F Y, ZHENG H, et al. lncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1α[J]. Theranostics, 2019, 9(18):5298-5314. [16] TIAN X P, WANG C Y, JIN X H, et al. Acidic microenvironment up-regulates exosomal miR-21 and miR-10b in early-stage hepatocellular carcinoma to promote cancer cell proliferation and metastasis[J]. Theranostics, 2019, 9(7):1965-1979. [17] XU K, ZHAN Y P, YUAN Z T, et al. Hypoxia induces drug resistance in colorectal cancer through the HIF-1α/miR-338-5p/IL-6 feedback loop[J]. Mol Ther, 2019, 27(10):1810-1824. [18] KONG W, HE L, RICHARDS E J, et al. Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer[J]. Oncogene, 2014, 33(6):679-689. [19] CHOUDHRY H, HARRIS A L. Advances in hypoxia-inducible factor biology[J]. Cell Metab, 2018, 27(2):281-298. [20] SABRY D, EL-DEEK S E M, MAHER M, et al. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma:impact of HIF-1α-VEGF signaling pathway[J]. Mol Cell Biochem, 2019, 454(1/2):177-189. [21] PRANZINI E, LEO A, RAPIZZI E, et al. MiR-210-3p mediates metabolic adaptation and sustains DNA damage repair of resistant colon cancer cells to treatment with 5-fluorouracil[J]. Mol Carcinog, 2019, 58(12):2181-2192. [22] SABA F, SOLEIMANI M, ABROUN S. New role of hypoxia in pathophysiology of multiple myeloma through miR-210[J]. EXCLI J, 2018, 17:647-662. [23] WANG Z G, DENG M S, LIU Z D, et al. Hypoxia-induced miR-210 promoter demethylation enhances proliferation, autophagy and angiogenesis of schwannoma cells[J]. Oncol Rep, 2017, 37(5):3010-3018. [24] ZHANG Y C, CHEN Z Y, FENG L X, et al. Ionizing radiation-inducible microRNA-21 induces angiogenesis by directly targeting PTEN[J]. Asian Pac J Cancer Prev, 2019, 20(5):1587-1593. [25] SONG L L, LIU S K, ZHANG L, et al. MiR-21 modulates radiosensitivity of cervical cancer through inhibiting autophagy via the PTEN/Akt/HIF-1α feedback loop and the Akt-mTOR signaling pathway[J]. Tumour Biol, 2016, 37(9):12161-12168. [26] LI L, LI C, WANG S X, et al. Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype[J]. Cancer Res, 2016, 76(7):1770-1780. [27] SZEBENI G J, VIZLER C, KITAJKA K, et al. Inflammation and cancer:Extra-and intracellular determinants of tumor-associated macrophages as tumor promoters[J]. Mediators Inflamm, 2017, 2017:9294018. [28] WANG J F, YU F, JIA X M, et al. microRNA-155 deficiency enhances the recruitment and functions of myeloid-derived suppressor cells in tumor microenvironment and promotes solid tumor growth[J]. Int J Cancer, 2015, 136(6):602-613. [29] CHI Y B, LUO Q C, SONG Y T, et al. Circular RNA circPIP5K1A promotes non-small cell lung cancer proliferation and metastasis through miR-600/HIF-1α regulation[J]. J Cell Biochem, 2019, 120(11):19019-19030. [30] DANG R Y, LIU F L, LI Y. Circular RNA hsa_circ_0010729 regulates vascular endothelial cell proliferation and apoptosis by targeting the miR-186/HIF-1α Axis[J]. Biochem Biophys Res Commun, 2017, 490(2):104-110. |
| [1] | ZHAO Yan, SUN Zhenxiao. Metformin inhibitd proliferation and migration of human breast cancer cell in vitro [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(1): 35-39. |
| [2] | . [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2022, 34(1): 72-74. |
| [3] | WANG Miao, WANG Quankai, LI Xinwei, MA Shunpeng, WUHAN Baolier, XU Jianning. m6A methylation of mRNAs in glycidyl methacrylate-induced malignant transformation of 16HBE cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 405-409. |
| [4] | LIU Ning, LIANG Lanlan, LI Shufang, SHEN Xiangchun, LIANG Bing. Anti-tumor effects of oxymatrine on mouse sarcoma and live cancers in vivo and in vitro [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 426-429,434. |
| [5] | GAO Xiaobin, WU Xueliang, WANG Shengjie, SUN Guangyuan, WANG Wenjing, LIANG Feng, ZHAO Yifeng, LIU Zhenxian, ZHANG Yingchun. Expression of TRIM59 and its correlations with clinicopathological features in colorectal cancers [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 446-450. |
| [6] | . [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 470-474. |
| [7] | . [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(6): 475-481. |
| [8] | ZHANG Zongming. Does thyroid microcarcinoma require surgery [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(5): 325-326. |
| [9] | CHENG Shujun. Aging and malignant tumor─Thought on prevention and control [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(3): 161-162. |
| [10] | ZHANG Die, LIU Xianghe, HUO Miaomiao, LIU Mei, XU Ningzhi, ZHU Hongxia. Effects of miR-195-5p on radiosensitivity of esophageal squamous cell carcinoma cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(2): 81-88,94. |
| [11] | CUI Zhaoyang, LI Suna, JIANG Xuqian, WANG Yidan, HOU Liying. Activation of the TRAIL death receptor by apigenin for induction of apoptosis in the gastric cancer SGC-7901 cells [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(1): 32-36. |
| [12] | . [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(1): 66-71,76. |
| [13] | . [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2021, 33(1): 72-76. |
| [14] | LI Jinglei, HOU Wei. ceRNA network-based stigmasterolintervention on lung squamous cell carcinoma [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 423-429. |
| [15] | SHI Hailin, HE Tianji, LIU Feng, CAI Menghui, GE Bo. Prognostic value of TCGA-database mutation burden in muscle-invasive bladder cancers [J]. Carcinogenesis, Teratogenesis & Mutagenesis, 2020, 32(6): 430-437,443. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
